Program
bitopertin
Also written as “RO4917838”, “bitopertin [RO4917838]” and “DISC-1459”.
Its studies are mostly in Schizophrenia · Protoporphyria, Erythropoietic · beta-Thalassemia · Obsessive-Compulsive Disorder, led by 2 companies.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Hoffmann-La Roche | 230 open or running | phase 3since Aug 30, 2010 | Feb 4, 2008 | none ahead |
| Disc Medicine | 31 open or running | phase 3since May 22, 2023 | Mar 21, 2022 | Jun 2028phase 3 · NCT05883748 |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 12 studies since Feb 4, 2008.
- Aug 31, 2011Phase 1 study in Healthy VolunteerHoffmann-La Roche · NCT01433575 · 16 enrolled · China
- Sep 21, 2011Phase 1 study in Healthy VolunteerHoffmann-La Roche · NCT01438749 · 177 enrolled · United States
- Dec 15, 2011Phase 1 study in Healthy VolunteerHoffmann-La Roche · NCT01495104 · 18 enrolled · France
- Jan 12, 2012Phase 1 study in Healthy VolunteerHoffmann-La Roche · NCT01510899 · 12 enrolled · France, Russian Federation
- Feb 28, 2012Phase 1 study in Healthy VolunteerHoffmann-La Roche · NCT01543529 · 25 enrolled · France
- May 23, 2012Phase 1 study in Healthy VolunteerHoffmann-La Roche · NCT01613040 · 169 enrolled · United States, France
- Jul 6, 2012Phase 1 study in Healthy VolunteerHoffmann-La Roche · NCT01636492 · 71 enrolled · New Zealand
- Aug 14, 2012Phase 1 study in Healthy VolunteerHoffmann-La Roche · NCT01665976 · 16 enrolled · France
- Aug 15, 2012Phase 2 study in Obsessive-Compulsive DisorderHoffmann-La Roche · NCT01674361 · 99 enrolled · United States, Canada
- Dec 18, 2013Phase 1 study in Healthy VolunteerHoffmann-La Roche · NCT02019290
- Sep 1, 2017Phase 2 study in beta-ThalassemiaHoffmann-La Roche · NCT03271541 · 12 enrolled · Italy, Lebanon, Thailand
- Mar 21, 2022Disc Medicine's first study: phase 2 study in Protoporphyria, ErythropoieticNew to Disc MedicineDisc Medicine · NCT05308472 · 75 enrolled · United States
- May 22, 2023Phase 3 study in Protoporphyria, ErythropoieticDisc Medicine · NCT05883748 · 230 planned · United States, Australia, Belgium and more
- Mar 17, 2025Phase 3 study in Protoporphyria, ErythropoieticDisc Medicine · NCT06910358 · 183 enrolled · United States, Australia, Belgium and more
Ahead
- Jun 2028Primary completion: phase 3 study in Protoporphyria, ErythropoieticDisc Medicine · NCT05883748
TargetBeta
“Glycine transporter 1 inhibitor”ChEMBL 37, by rule
Studies
All 26 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT06910358Protoporphyria, Erythropoietic · United States, Australia, Belgium and more | 3 | Completed | Disc Medicine | Sep 8, 2026 | 183 |
| NCT05883748Protoporphyria, Erythropoietic · United States, Australia, Belgium and more | 3 | By invitation | Disc Medicine | Jun 2028 | 230 |
| NCT05308472Protoporphyria, Erythropoietic · United States | 2 | Completed | Disc Medicine | Feb 20, 2024 | 75 |
| NCT03271541beta-Thalassemia · Italy, Lebanon, Thailand | 2 | Completed | Hoffmann-La Roche | Jun 29, 2018 | 12 |
| NCT02019290Healthy Volunteer | 1 | Withdrawn | Hoffmann-La Roche | Mar 31, 2014 | 0 |
| NCT01674361Obsessive-Compulsive Disorder · United States, Canada | 2 | Completed | Hoffmann-La Roche | Apr 30, 2015 | 99 |
| NCT01665976Healthy Volunteer · France | 1 | Completed | Hoffmann-La Roche | Nov 2012 | 16 |
| NCT01636492Healthy Volunteer · New Zealand | 1 | Completed | Hoffmann-La Roche | Aug 2006 | 71 |
| NCT01613040Healthy Volunteer · United States, France | 1 | Completed | Hoffmann-La Roche | Jul 2009 | 169 |
| NCT01543529Healthy Volunteer · France | 1 | Completed | Hoffmann-La Roche | Jun 4, 2012 | 25 |
| NCT01510899Healthy Volunteer · France, Russian Federation | 1 | Completed | Hoffmann-La Roche | Mar 2012 | 12 |
| NCT01495104Healthy Volunteer · France | 1 | Completed | Hoffmann-La Roche | Jan 2012 | 18 |
| NCT01438749Healthy Volunteer · United States | 1 | Completed | Hoffmann-La Roche | May 2012 | 177 |
| NCT01433575Healthy Volunteer · China | 1 | Completed | Hoffmann-La Roche | Nov 2011 | 16 |
| NCT01365403Healthy Volunteer · France | 1 | Completed | Hoffmann-La Roche | Jul 2011 | 16 |
| NCT01356550Healthy Volunteer · France, Russian Federation | 1 | Completed | Hoffmann-La Roche | Oct 2011 | 35 |
| NCT01234779Schizophrenia · United States, Romania, Russian Federation and more | 2 | Completed | Hoffmann-La Roche | Sep 2012 | 301 |
| NCT01235585Schizophrenia · United States, Brazil, Canada and more | 3 | Completed | Hoffmann-La Roche | Sep 2014 | 597 |
| NCT01235559Schizophrenia · United States, Bulgaria, China and more | 3 | Completed | Hoffmann-La Roche | Mar 2015 | 604 |
| NCT01235520Schizophrenia · United States, Argentina, Australia and more | 3 | Completed | Hoffmann-La Roche | Jul 2014 | 595 |
| NCT01192906Schizophrenia · United States, Brazil, Canada and more | 3 | Completed | Hoffmann-La Roche | Jul 2014 | 624 |
| NCT01192880Schizophrenia · United States, Bulgaria, China and more | 3 | Completed | Hoffmann-La Roche | Jul 2014 | 625 |
| NCT01192867Schizophrenia · United States, Argentina, Australia and more | 3 | Completed | Hoffmann-La Roche | May 26, 2014 | 629 |
| NCT01183585Healthy Volunteer · France | 1 | Completed | Hoffmann-La Roche | Sep 2010 | 18 |
| NCT01116830Schizophrenia · United States | 1 | Completed | Hoffmann-La Roche | Feb 2014 | 29 |
| NCT00616798Schizophrenia · United States, Austria, Brazil and more | 2 | Completed | Hoffmann-La Roche | Feb 2010 | 323 |
How it is read
Names in the registry
- “RO4917838”, 20 entries
- “bitopertin [RO4917838]”, 6 entries
- “DISC-1459”, 5 entries
- “Bitopertin”, 3 entries
- “bitopertin”, 2 entries
Conditions, from the studies’ own filings
- Schizophrenia, 9 studies
- Protoporphyria, Erythropoietic, 3 studies
- beta-Thalassemia, 1 study
- Obsessive-Compulsive Disorder, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.